Clinical study on Guben Kechuan Capsules combined with ipratropium bromide in treatment of chronic bronchitis
Ya-qin CHAI,Fang-hong ZHU
DOI: https://doi.org/10.7501/j.issn.1674-5515.2017.12.020
2017-01-01
Abstract:Objective To investigate the clinical effect of Guben Kechuan Capsules combined with Ipratropium Bromide Solution for inhalation in treatment of chronic bronchitis. Methods Patients (100 cases) with chronic bronchitis in Xian XD Group Hospital from January 2015 to December 2016 were enrolled in this study. According to different treatment plans, patients were divided into the control group (48 cases) and the treatment group (52 cases). Patients in the control group were aerosol inhalation administered with Ipratropium Bromide Solution for inhalation, 2 mL/time, twice daily. Patients in the treatment group were po administered with Guben Kechuan Capsules on the basis of the control group, 3 grains/time, three times daily. Patients in two groups were treated for 3 months. After treatment, the clinical efficacies were evaluated, and symptom scores, serum indexes, blood gas indexes, and symptom disappearance time in two groups were compared. Results After treatment, the clinical efficacies in the control and treatment groups were 77.08% and 96.15%, respectively, and there was difference between two groups (P < 0.05). After treatment, cough score, expectoration score, asthma score, and total score in two groups were significantly decreased, and the difference was statistically significant in the same group (P < 0.05). And the observational indexes in the treatment group were significantly lower than those in the control group, with significant difference between two groups (P < 0.05). After treatment, the IgAand IgG in two groups were significantlyincreased, but the levels of TNF-α and IL-6 in two groups were significantly decreased, and the difference was statistically significant in the same group (P < 0.05). And the observational indexes in the treatment group were significantly better than those in the control group, with significant difference between two groups (P < 0.05). After treatment, the pH value and pO2 in two groups were significantly increased, but the levels of pCO2 in two groups were significantly decreased, and the difference was statistically significant in the same group (P < 0.05). And the observational indexes in the treatment group were significantly better than those in the control group, with significant difference between two groups (P < 0.05). After treatment, the disappearance times of wheezing, coughing and expectoration in the treatment group were significantly shorter than those in the control group, and there was difference between two groups (P < 0.05). Conclusion Guben Kechuan Capsules combined with Ipratropium Bromide Solution for inhalation has clinical curative effect in treatment of chronic bronchitis, can significantly improve clinical symptom, decrease the inflammatory level, and regulate the immune function, with good safety, which has a certain clinical application value.